Deksametazon Accord 4 mg/ml otopina za injekciju/infuziju
Name | Deksametazon Accord 4 mg/ml otopina za injekciju/infuziju |
---|---|
Marketing Authorisation Number | HR-H-372263694 |
Active Substance | natrijev deksametazonfosfat |
Composition | 1 ml otopine sadrži 4 mg deksametazonfosfata (u obliku natrijevog deksametazonfosfata) |
Pharmaceutical Form | Otopina za injekciju / infuziju |
Manufacturer | Pharmadox Healthcare Limited, Paola, Malta Laboratori Fundacio Dau, Barcelona, Španjolska Accord Healthcare Polska Sp. z o.o., Pabianice, Poljska |
Marketing Authorisation Holder | Accord Healthcare Polska Sp. z o.o., Ul. Tasmowa 7, Mazowieckie, Varšava, Poljska |
Marketing Authorisation Date | 20.06.2024 |
MA Period of Validity | 20.06.2029 |
Classification Number | UP/I-530-09/22-01/59 |
Registration Number | 381-12-01/70-24-09 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | H02AB02 |
SmPC | download |
PL | download |